Genomics in Scotland strategy: business and regulatory impact assessment
Business and regulatory impact assessment (BRIA) for the Genomics in Scotland: Building our Future five-year national strategy (2024 to 2029).
8. Consumer Assessment
The strategy, which aims to improve access to genomic testing for patients in Scotland, will not have a negative impact on consumers.
Contact
Email: holly.ennis@gov.scot
There is a problem
Thanks for your feedback